Document:

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Exhibit 10.16

  
 CONSULTING MANAGEMENT AGREEMENT
 

 

 THIS AGREEMENT (the "Agreement") effective as of the March 26, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc., a Nevada Corporation, with its principal registered address of 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 USA email:  chad.johnson@cannabisscience.com (the “Company” or “CBIS”) Derwin Wallace  6067 Fairington Farms Lane, Lithonia, GA 30038 (hereinafter referred to as the “CONSULTANT”) in connection with the provision of the CONSULTANT’s services to the Company.  The Company and the CONSULTANT may be referred to herein as the "Parties" or each as a "Party".
 

 WHEREAS:
 

 A.
 The Company is in the business of developing, manufacturing, marketing, and distributing legal cannabinoid-based and other products, particularly pharmaceutical products, worldwide;
  
 B.
 The CONSULTANT will be a Managing CONSULTANT of the Company, and this Agreement will supersede any management consulting agreement with the Company.
 

 C.
 The Company wishes to engage the services of the CONSULTANT to serve as CONSULTANT to the Company, using best efforts in the mission to further the interests of the Company; and
 

 D.
 The Company and the CONSULTANT have agreed to enter into a CONSULTANT management agreement for their mutual benefit.
 

 THIS AGREEMENT WITNESSES THAT in consideration of the premises and mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound hereby, agree as follows:
 

 1.
 ENGAGEMENT AS CONSULTANT
 

 1.1
 The Company hereby engages the Consultant to work exclusively as an independent contractor of the Company, to undertake the duties and title of Investor Relations exclusively for the Company on a fulltime basis, unless mutually agreed by both parties.  The Company retains the rights to be unencumbered to work with other Investor Relations consultants as it chooses. The Consultant agrees to exercise those powers as reasonably requested by the Company or its subsidiaries from time to time, (collectively the “Services”) and the Consultant accepts such engagement on the terms and conditions set forth in this Agreement.
 

 2.
 TERM OF THIS AGREEMENT
 

 2.1
 The term of this Agreement shall begin as of the Effective Date and shall continue for one (1) year or until terminated earlier pursuant to Sections 10 and 11 herein (the “Term”).  Any renewal period for this Agreement shall be at the sole discretion of the Company along with the renewal term including any compensation for services during the renewal term.
  
 3.
 CONSULTANT SERVICES
 

 3.1
 The CONSULTANT shall undertake and perform the documentation and tracking of the Company’s complete investor relations protocols as directed by the President & CEO along with the duties and responsibilities commonly associated with acting in the capacities of investor relations.  The CONSULTANT agrees that his duties may be reasonably modified at the Company’s and the CONSULTANT’s mutual agreement from time to time.
  
 	 1

	              

 

 

 3.2
 In providing the Services the CONSULTANT shall:
 	 comply with all applicable local, state, provincial, national and federal statutes, laws and regulations;
 
	not make any misrepresentation or omit to state any material fact which results in a misrepresentation regarding the business of the Company;  
	not disclose, release or publish any information regarding the Company without the prior written consent of the Company; and 
	not employ any person in any capacity, or contract for the purchase or rental of any service, article or material, nor make any commitment, agreement or obligation whereby the Company shall be required to pay any monies or other consideration without the Company's prior written consent as provided by the Company's Board of Directors. 

 4.
 CONSULTANT COMPENSATION
 

 4.1
 Shares.  the Company shall pay the CONSULTANT for the provision of the Services, the Company shall pay the CONSULTANT or his assigns two million five hundred thousand (2,500,000) newly issued Rule 144 restricted common shares of Company common stock, par value $0.001 per share and two million five hundred thousand (2,500,000) newly issued options to purchase common shares of Company common stock, at $0.04 per share.
 

 4.2
 Performance Bonus. As further compensation based on job performance, product development and branding, product sales, achievement of project or operational milestones, the Company is committed to providing an additional bonus schedule for the CONSULTANT on a semi-annual basis in the form of stock, options, or cash payments at the discretion of the Company.
 

 5.
 CONSULTANT EXPENSES AND DEVELOPMENT COSTS
 

 5.1
 The Parties agree that the Compensation hereunder shall be inclusive of any and all fees or expenses incurred by the CONSULTANT on the CONSULTANT’s own behalf pursuant to this Agreement including but not limited to the costs of rendering the Services.  Notwithstanding the foregoing, the Company shall reimburse the CONSULTANT for any bona fide expenses such as travel and telephone incurred by the CONSULTANT on behalf of the Company in connection with the provision of the Services provided that the CONSULTANT submits to the Company an itemized written account of such expenses and corresponding receipts of purchase in a form acceptable to the Company within 10 days after the CONSULTANT incurs such expenses.  However, the Company shall have no obligation to reimburse the CONSULTANT for any single expense in excess of $5,000 or $10,000.00 in the aggregate without the express prior written approval of the Company’s Board of Directors.
 

 6. 
 CONFIDENTIALITY
 

 6.1
 The CONSULTANT shall not disclose to any third party without the prior consent of the Company any financial or business information concerning the business, affairs, plans and programs of the Company its Directors, officers, shareholders, employees, or CONSULTANTs (the "Confidential Information").  The CONSULTANT shall not be bound by the foregoing limitation in the event (i) the Confidential Information is otherwise disseminated and becomes public information or (ii) the CONSULTANT is required to disclose the Confidential Informational pursuant to a subpoena or other judicial order.  As a material inducement to the Company entering into this Agreement, the CONSULTANT shall, at the Company’s request, execute a confidentiality and non-disclosure agreement in a form mutually agreed upon by the Company and the CONSULTANT.
 

 7. 
 GRANTS OF RIGHTS AND INSURANCE
 

 7.1
  The CONSULTANT agrees that the results and proceeds of the Services under this Agreement, although not created in an employment relationship, shall, for the purpose of copyright only, be deemed a work made in the course of employment under the Canadian law or a work-made-for-hire under the United States law and all other comparable international intellectual property laws and conventions.  All intellectual property rights and any other rights which the CONSULTANT may have in and to any work, materials, or other results and proceeds of the Services hereunder shall vest irrevocably and exclusively with the Company and are otherwise hereby assigned to the Company as and when created.  The CONSULTANT hereby waives any moral rights of authors or similar rights the CONSULTANT may have in or to the results and proceeds of the consulting Services hereunder.
 

 7.2
 The CONSULTANT retains the right of prior approval of any public statements or publications by the Company using the CONSULTANT's name, such as press releases and website pages.
  
 7.3
 The Company shall have the right to apply for and take out, at the Company's expense, life, health, accident, or other insurance covering the CONSULTANT, in any amount the Company deems necessary to protect the Company's interest hereunder.  The CONSULTANT shall not have any right, title, or interest in or to such insurance.
  
  	 2

	              

 8.  
 REPRESENTATIONS AND WARRANTIES
 

 8.1
 The CONSULTANT represents, warrants and covenants to the Company as follows: 
 

 (a)
 The CONSULTANT is not under any contractual or other restriction which is inconsistent with the execution of this Agreement, the performance of the Services hereunder or any other rights of the Company hereunder;
 

 (b)
 The CONSULTANT is not under any physical or mental disability that would hinder the performance of her duties under this Agreement; and
 

 (c)
 The Company will provide and disclose all legal and commercial information to the CONSULTANT that is necessary to perform CONSULTANT’s duties.
 

 9.  
 INDEMNIFICATION
 

 9.1 
 Each Party shall indemnify and hold harmless the other Party, its partners, financiers, parent, affiliated and related companies, and all of their respective individual shareholders, directors, officers, employees, attorneys, auditors, licensees and assigns from and against any claims, actions, losses and expenses (including legal expenses) occasioned by any breach by the Party of any representations and warranties contained in, or by any breach of any other provision of, this Agreement by the Party.
 

 10. 
  NO OBLIGATION TO PROCEED.  
 

 10.1
 Nothing herein contained shall in any way obligate the Company to use the Services hereunder or to exploit the results and proceeds of the Services hereunder; provided that, upon the condition that the CONSULTANT is not in material default of the terms and conditions hereof, nothing contained in this section 10.1 shall relieve the Company of its obligation to deliver to the CONSULTANT the Compensation.  All of the foregoing shall be subject to the other terms and conditions of this Agreement (including, without limitation, the Company’s right of termination, disability and default).
 

 11. 
 RIGHT OF TERMINATION.  
 

 11.1
 The Company and the CONSULTANT shall each have the right to terminate this Agreement at any time in its sole discretion by giving not less than ninety (90) days written notice. Upon termination of this Agreement the CONSULTANT shall continue to work with the Company to fulfill the obligations of this Agreement during the notice period and this period will be paid for per terms of this Agreement.
 .
 12. 
 DEFAULT/BREACH 
 

 12.1
 No act or omission of the Company hereunder shall constitute an event of default or breach of this Agreement unless the CONSULTANT shall first notify the Company in writing setting forth such alleged breach or default and the Company shall cure said alleged breach or default within 10 days after receipt of such notice (or commence said cure within said ten days if the matter cannot be cured in ten days, and shall diligently continue to complete said cure).  No act or omission of the CONSULTANT hereunder shall constitute an event of default or breach of this Agreement unless the Company shall first notify the CONSULTANT in writing setting forth such alleged breach or default and the CONSULTANT shall cure said alleged breach or default within 10 days after receipt of such notice (or commence said cure within said ten days if the matter cannot be cured in ten days, and shall diligently continue to complete said cure).  Either Party may terminate the Agreement if there is an event of default or breach of this Agreement that the other Party does not cure or attempt to cure pursuant to the clear intent of this Section.
 

 13. 
 COMPANY'S REMEDIES.  
 

 13.1
 The services to be rendered by the CONSULTANT hereunder and the rights and privileges herein granted to the Company are of a special, unique, unusual, extraordinary and intellectual character which gives them a peculiar value, the loss of which cannot be reasonably or adequately compensated in damages in an action at law, it being understood and agreed that a breach by the CONSULTANT of any of the provisions of this Agreement shall cause the Company irreparable injury and damages.  The CONSULTANT expressly agrees that the Company shall be entitled to seek injunctive and/or other equitable relief to prevent a breach hereof the CONSULTANT.  Resort to such equitable relief, however, shall not be construed as a waiver of any other rights or remedies which the Company may have in the premises for damages or otherwise.
 

 14.
 INDEPENDENT CONTRACTORS.  
 

 14.1 Nothing herein shall be construed as creating a partnership, joint venture, or master-servant relationship between the Parties for any purpose whatsoever.  Except as may be expressly provided herein, neither Party may be held responsible for the acts either of omission or commission of the other Party, and neither Party is authorized, or has the power, to obligate or bind the other Party by contract, agreement, warranty, representation or otherwise in any manner except by agreement the Company's Board of Directors.  It is expressly understood that the legal relationship between the Parties is one of independent contractors. 
 

  	 3

	              

 15. 
 MISCELLANEOUS PROVISIONS
 

 (a)
 Time.  Time is of the essence of this Agreement.
 

 (b)
 Presumption.  This Agreement or any section thereof shall not be construed against any Party due to the fact that said Agreement or any section thereof was drafted by said Party.
 

 (c)
 Titles and Captions.  All article, section and paragraph titles or captions contained in this Agreement are for convenience only and shall not be deemed part of the context nor affect the interpretation of this Agreement.
 

 (d)
 Further Action.  The Parties hereto shall execute and deliver all documents, provide all information and take or forbear from all such action as may be necessary or appropriate to achieve the purposes of this Agreement.
 

 (e)
 Savings Clause.  If any provision of this Agreement, or the application of such provision to any person or circumstance, shall be held invalid, the remainder of this Agreement, or the application of such provision to persons or circumstances other than those as to which it is held invalid, shall not be affected thereby.
 

 (f)
 Assignment. The Company and the CONSULTANT may assign this Agreement only with the prior written consent of the other Party. 
 

 (g)
 Notices.  All notices required or permitted to be given under this Agreement shall be given in writing and shall be delivered, either personally or by express delivery service, and emailed to, the Party to be notified.  Notice to each Party shall be deemed to have been duly given upon delivery, personally or by courier, to the physical and email addresses of the other Party at that Party's physical and email addresses provided on page one (1) of this Agreement, which may be updated over time with at least ten days written notice, to the other Party.  
 

 (h)
 Entire Agreement.  This Agreement contains the entire understanding and agreement among the Parties.  There are no other agreements, conditions or representations, oral or written, express or implied, with regard thereto.  This Agreement may be amended only in writing signed by all Parties.  This Agreement supersedes prior management and/or consulting agreements with the Company and the CONSULTANT.
 

 (i)
 Waiver.  A delay or failure by any Party to exercise a right under this Agreement, or a partial or single exercise of that right, shall not constitute a waiver of that or any other right.
 

 (j)
 Counterparts.  This Agreement may be executed in duplicate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same Agreement.  Counterparts expressly may include electronic counterparts with electronic signatures transmitted through electronic means.
 

 (k)
 Successors.  The provisions of this Agreement shall be binding upon all Parties, their successors and permitted assigns. 
 

 (l)
 Counsel.  The Parties expressly acknowledge that each has been advised to seek separate counsel for advice in this matter and has been given a reasonable opportunity to do so.
 

 [Signature Page Follows]
 

  	 4

	              

 

 IN WITNESS WHEREOF, the Parties have duly executed and delivered this Agreement as of the date first written above.
 

 

 

 CANNABIS SCIENCE, INC. 
  
 Per: /s/ Raymond C. Dabney
 ________________________________
  Raymond C. Dabney, President & CEO
 

 

 

 

 

 CONSULTANT:
  
 By: /s/ Derwin Thomas
 _______________________________
 Derwin Thomas
 

 

 

 

  	 5Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Exhibit 10.17

  
 DEBT SETTLEMENT AGREEMENT
 

 THIS AGREEMENT is dated for reference the 20th day of February, 2015.
 

 BETWEEN:
 

 Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254, Colorado Springs, CO 80918
 

 (the “Company”)
 

 OF THE FIRST PART
 

 AND:
 

 Intrinsic Capital Corp., a company incorporated under the laws of Nevada, having an address at #1516 E. Tropicana Ave, Suite 155, Las Vegas NV 89119
 

 (the “Creditor”)
 

 OF THE SECOND PART
 

 WHEREAS:
 

 A.
 The Company is indebted to the Creditor in the total amount of US $30,828.08 (the “Debt”) as at February 20, 2015;
 

 B.
 The Company wishes to settle the Debt by issuing to the Creditor, or its assigns, shares of common stock of the Company and the Creditor is prepared to accept the shares in full satisfaction of the Debt.
 

 NOW THEREFORE THIS AGREEMENT WITNESSES that, in consideration of the premises and of the covenants and agreements set out in this Agreement, the parties agree as follows:
 

 1.
 ACKNOWLEDGMENT OF DEBT
 

 1.1
 The Company acknowledges and agrees that it is indebted to the Creditor in the amount of the Debt.
 

 1.2
 The Debt was recorded on the books of the Company on July 23, 2013 ($18,328.08), August 15, 2013 ($1,250), August 30, 2013 ($1,250), and September 9, 2013 ($10,000) for a total of $30,828.08.
 

 2.
 ISSUANCE OF SHARES
 

 2.1 
 The Company agrees to issue to the Creditor and the Creditor agrees to accept 30,828,080 shares of common stock of the Company (the “Shares”) at a deemed price of US $0.001 per Share as full and final payment of the Debt.
 

 2.2 
 The Creditor agrees that the Debt will be fully satisfied and extinguished when the Company delivers the Shares to the Creditor, and subject only to the issuance of the Shares, the Creditor releases and forever discharges the Company, its subsidiaries and their respective directors, officers, and employees from and against any and all claims, actions, obligations, and damages whatsoever which the Creditor may have against any of them relating to the Debt.  This release will be operative from and after the date of completion of the transaction contemplated by this Agreement and will be effective without the delivery of any further release or other documents by the Creditor to the Company.
 
 	 1

	              

 3.
 REPRESENTATIONS OF CREDITOR
 

 The Creditor represents, warrants and acknowledges to the Company that:
 

 (a) 
 the Debt constitutes the outstanding indebtedness with respect to the Debt of the Company to the Creditor as at February 20, 2015, including principal, interest to the date hereof and costs;
 

 (b) 
 the Creditor has not conveyed, transferred or assigned any portion of the Debt to any third party, and has full right, power and authority to enter into this Agreement and to accept the Shares in full and final satisfaction of the Debt;
 

 (c) 
 no third party has any right to payment of all or any portion of the Debt;
  
 (d) 
 the Creditor has no claims or potential claims against the Company on account of any matter
 whatsoever, other than the Debt;
  
 (e) 
 if the Creditor is a corporation or legal entity other than an individual, all necessary corporate or other action has been taken by the Creditor to approve this Agreement;
 

 (f)
  the Company is relying on exemptions from registration and prospectus requirements of applicable securities laws in the United States to issue the Shares to the Creditor;
 

 (g) 
 the Creditor is not acquiring the Shares as a result of any material information that the Company has not generally disclosed to the public; and
 

 (h)
  the Shares will be subject to resale restrictions as required by applicable securities law and the
 Creditor will seek its own independent legal advice regarding such resale restrictions imposed on the Shares.

 The Company’s obligation to complete the transactions contemplated hereby is subject to the foregoing representations and warranties being true and correct at the date of this Agreement and at the time of closing.  Such representations and warranties will survive the closing of the transactions contemplated hereby and will continue in full force and effect for the benefit of the Company for a period of five years from the date of issuance of the Shares to the Creditor.  The Creditor will indemnify the Company from and against any and all claims, damages, losses and costs arising from such representations ad warranties being incorrect or breached.
 

 4.
 GENERAL PROVISIONS
 

 4.1 
 Time will be of the essence of this Agreement.
 

 4.2 
 The Company and the Creditor will sign all other documents and do all other things reasonably necessary to carry out this Agreement.
 

 4.3 
 The provisions contained in this Agreement constitute the entire agreement between the parties and supersede all previous understandings, communications, representations, and agreements, whether written or verbal, between the parties regarding the subject matter of this Agreement.
 

 4.4 
 All dollar amounts referred to in this Agreement are expressed in United States currency, unless otherwise indicated.
 

 4.5 
 This Agreement will enure to the benefit of and be binding on each of the parties and their respective heirs, executors, administrators, successors, and assigns.
 

 4.6 
 This Agreement may be signed in counterparts, both of which will constitute one agreement.
 

 4.7 
 This Agreement supersedes and replaces any prior agreements between the parties concerning the subject matter hereof.
  
  	 2

	              

 

 IN WITNESS WHEREOF the parties have signed this Agreement as of the date written on the first page of this Agreement.
  
 

 CANNABIS SCIENCE, INC
 

 Per:    /s/ Raymond C. Dabney
 ____________________________________
 Raymond C. Dabney, Director and President
 

 

 Intrinsic Capital Corp.
 

 Per:      /s/ J. Scott Munro
 

 ________________________________________________________________________________________________
 J. Scott Munro, President
 

  
  	 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}]]